Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Neutropenic Enterocolitis
2009
The Pseudomonas aeruginosa accessory genome elements influence virulence towards Caenorhabditis elegans
2019 StandoutNobel
Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
2013
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
2006 Standout
Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role?
2014
Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study
2014
Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies
2005
Risk Factors and Predictors of Outcome in Patients with Cancer and Breakthrough Candidemia
2001
Prevention and control of health care–associated waterborne infections in health care facilities
2005
The microbiology of necrotizing soft tissue infections
2000
MONOTHERAPY WITH PIPERACILLIN/TAZOBACTAM VERSUS CEFEPIME AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC CANCER PATIENTS: A Randomized Comparison
2006
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Management of gram-positive bacterial infections in patients with cancer
2011
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Limited Value of Routine Microbiological Diagnostics in Patients Hospitalized for Community-acquired Pneumonia
2002
Risk Assessment and Treatment of Low-Risk Patients with Febrile Neutropenia
2006
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
An Intervention To Improve Antibiotic Delivery and Sputum Procurement in Patients Hospitalized With Community-Acquired Pneumonia
2002
Safety of triazole antifungal drugs in patients with cancer
2009
Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia
2005
Hospital water point-of-use filtration: A complementary strategy to reduce the risk of nosocomial infection
2005
Intravenous Itraconazole followed by Oral Itraconazole for the Treatment of Amphotericin-B-Refractory Invasive Pulmonary Aspergillosis
2003
Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
2008
Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies
2006
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
2013
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
2005 Standout
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia
2005
Neutropenic enterocolitis
2006
Burden of Clostridium difficile Infection in the United States
2015 Standout
Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD)
2003
Update on antifungal treatment of invasive Candida and Aspergillus infections
2004
Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review
2012 Standout
Molecular Epidemiology of a Pseudomonas aeruginosa Hospital Outbreak Driven by a Contaminated Disinfectant-Soap Dispenser
2011
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
2010 Standout
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing
2008 Standout
Antifungal prophylaxis for severely neutropenic chemotherapy recipients
2002
Short Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging
2009 StandoutNobel
Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river
2005
The benefits of surface disinfection
2004
Antibiotic resistance in the environment
2021 Standout
Species determination and characterization of developmental stages of ticks by whole-animal matrix-assisted laser desorption/ionization mass spectrometry
2012
Neutropenic Enterocolitis
2009
Household cleaning and surface disinfection: new insights and strategies
2004
Multiplex PCR System for Rapid Detection of Pathogens in Patients with Presumed Sepsis – A Systemic Review and Meta-Analysis
2013
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
2015
A Randomized, Open-Label, Multicenter Comparative Study of the Efficacy and Safety of Piperacillin-Tazobactam and Cefepime for the Empirical Treatment of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies
2006
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Cluster of Pseudomonas aeruginosa catheter-related bloodstream infections traced to contaminated multidose heparinized saline solutions in a medical ward
2006
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Neutropenic enterocolitis in adults: systematic analysis of evidence quality
2005
Early Stop Polymorphism in Human DECTIN‐1 Is Associated with Increased Candida Colonization in Hematopoietic Stem Cell Transplant Recipients
2009
Immunity to fungal infections
2011 Standout
Herpes Zoster
2013 Standout
Vancomycin does not benefit persistently febrile neutropenic people with cancer
2004
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole
2007
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea
2013
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2003
Assessment of the Usefulness of Sputum Culture for Diagnosis of Community-Acquired Pneumonia Using the PORT Predictive Scoring System
2004
Applying Sputum as a Diagnostic Tool in Pneumonia
2002
Bacterial lung sepsis in patients with febrile neutropenia
2012
The Contribution of Blood Cultures to the Clinical Management of Adult Patients Admitted to the Hospital With Community-Acquired Pneumonia
2003
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients
2007
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology
2009
Clostridium difficile infection and pseudomembranous colitis
2003
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Predicting Bacteremia in Patients with Community-Acquired Pneumonia
2003
Initial Microbiologic Studies Did Not Affect Outcome in Adults Hospitalized with Community-Acquired Pneumonia
1999
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
2012
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Nocardia mexicana sp. nov., a New Pathogen Isolated from Human Mycetomas
2004
PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
2010
MALDI-TOF-Mass Spectrometry Applications in Clinical Microbiology
2010
Azole-Based Energetic Salts
2011 Standout
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies
2003
Prevention and Treatment of Cancer-Related Infections
2012
Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs
1997
Current and Emerging Azole Antifungal Agents
1999 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
2000
Itraconazole
2000
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
2003
Invasive Candidiasis
2015 Standout
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2013
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Controlling Hospital-Acquired Infection: Focus on the Role of the Environment and New Technologies for Decontamination
2014
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination
2007
Voriconazole Therapeutic Drug Monitoring
2006
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
2008
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Prophylaxis against fungal infections and cytomegalovirus disease after bone marrow transplantation.
2000
Three Decades of β-Lactamase Inhibitors
2010 Standout
Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre: Rational approach towards the patient with cancer, fever and neutropenia
2005
Metallic Copper as an Antimicrobial Surface
2010 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome
2013
Interprofessional education: effects on professional practice and healthcare outcomes
2013 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients
2003
Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis
2007
Diagnostic Value of PCR Analysis of Bacteria and Fungi from Blood in Empiric-Therapy-Resistant Febrile Neutropenia
2010
Invasive Candida-Infektionen bei nichtneutropenischen Erwachsenen
2013
Itraconazole Preexposure Attenuates the Efficacy of Subsequent Amphotericin B Therapy in a Murine Model of Acute Invasive Pulmonary Aspergillosis
2002
Exame do escarro no manejo clínico dos pacientes com pneumonia adquirida na comunidade
2008
Guidelines for Treatment of Candidiasis
2004 Standout
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
2001
Update on Tick-Borne Rickettsioses around the World: a Geographic Approach
2013 Standout
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Safety, Pharmacokinetics, and Pharmacodynamics of Cyclodextrin Itraconazole in Pediatric Patients with Oropharyngeal Candidiasis
2002
Clinical and Laboratory Features of theNocardiaspp. Based on Current Molecular Taxonomy
2006 Standout
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Multiplex Blood PCR in Combination with Blood Cultures for Improvement of Microbiological Documentation of Infection in Febrile Neutropenia
2010
Works of G. Marklein being referenced
Value of Routine Microbial Investigation in Community-Acquired Pneumonia Treated in a Tertiary Care Center
1996
Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia
1999
Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl‐β‐cyclodextrin oral solution or coated‐pellet capsules
1999
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison
2003
Severe Abdominal Infections in Neutropenic Patients
2001
Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia
1998
Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology
2002
Pseudomonas aeruginosa outbreak in a haematology–oncology unit associated with contaminated surface cleaning equipment
2002
Mycetoma due toPseudallescheria boydiiand co-isolation ofNocardia abscessusin a patient injured in road accident
2002
Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole
1999
Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006
2010
Quinolones in Everyday Clinical Practice: Respiratory Tract Infections and Nosocomial Pneumonia
1996
False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?
2008
Necrotizing fasciitis caused byVibrio vulnificus: First published infection acquired in Turkey is the second time a strain is isolated in Germany
1998
Clostridium difficileInfection in Patients with Neutropenia
2001
An Audit of Efficacy and Toxicity of Teicoplanin Versus Vancomycin in Febrile Neutropenia: Is the Different Toxicity Profile Clinically Relevant?
2008
Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients
2001
[Nosocomial ventilator-associated pneumonias caused by Aspergillus fumigatus in non-immunosuppressed, non-neutropenic patients].
1998
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein
2004
Utility of a Commercially Available Multiplex Real-Time PCR Assay To Detect Bacterial and Fungal Pathogens in Febrile Neutropenia
2009
Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Fast and Reliable Identification of Clinical Yeast Isolates
2009